Schizophrenia and other psychotic disorders
Download
Report
Transcript Schizophrenia and other psychotic disorders
Schizophrenia and Other
Psychotic Disorders
Anita S. Kablinger MD
Associate Professor
Departments of Psychiatry
of Pharmacology
LSUHSC-Shreveport
What is Psychosis?
Generic term
“Break with Reality”
Symptom, not an illness
Caused by a variety of conditions
that affect the functioning of the
brain.
Includes hallucinations, delusions
and thought disorder
Differential Diagnosis
Medical/surgical/
substance-induced
Psychotic d/o due to GMC
Dementias
Delirium
Medications
Substance induced
Amphetamines
Cocaine
Withdrawal states
Hallucinogens
Alcohol
Mood disorders
Bipolar disorder
Major depression with
psychotic features
Mood disorders
“Functional”
disorders
Schizophrenia
“spectrum”
disorders
P
S
Y
C
H
O
S
I
S
Substance
induced
Delirium
Dementia
Amnestic d/o
“organic”
mental
disorders
Differential Diagnoses:
(Cont)
Personality
disorders
Schizoid
Schizotypal
Paranoid
Borderline
Antisocial
Miscellaneous
PTSD
Dissociative disorders
Malingering
Culturally specific phenomena:
Religious experiences
Meditative states
Belief in UFO’s, etc
Workup of New-Onset Psychosis:
“Round up the usual suspects”
Good clinical history
Physical exam, ROS
Labs/Diagnostic tests:
Metabolic panel
CBC with diff
B12, Folate
RPR, VDRL
Serum Alcohol
Urinalysis
Thyroid profile
URINE DRUG SCREEN!!!
CSF/LP
HIV serology
CT or MRI
EEG
Talking Points
Schizophrenia is not an excess of
dopamine.
The differentiation between “functional”
and “organic” is artificial.
Schizophrenia and other psychiatric
illnesses are syndromes.
Schizophrenia is a diagnosis of exclusion.
Talking Points
1% prevalence
Early onset, M>F
Early, aggressive treatment
decreases long-term problems
Multiple subtypes- catatonic,
disorganized, paranoid,
undifferentiated, residual
Schizophrenia
Diagnostic features
DSM-IV Diagnosis of
Schizophrenia
Psychotic symptoms (2 or more) for
at least one month
Hallucinations
Delusions
Disorganized speech
Disorganized or catatonic behavior
Negative symptoms
Diagnosis (cont.)
Impairment in social or occupational
functioning
Duration of illness at least 6 mo.
Symptoms not due to mood disorder
or schizoaffective disorder
Symptoms not due to medical,
neurological, or substance-induced
disorder
Clinical features:
Formal Thought Disorders
Neologisms
Tangentiality
Derailment
Loosening of associations (word
salad)
Private word usage
Perseveration
Nonsequitors
Clinical features:
Delusions
Paranoid/persecutory
Ideas of reference
External locus of
control
Thought broadcasting
Thought insertion,
withdrawal
Jealousy
Guilt
Grandiosity
Religious delusions
Somatic delusions
Clinical features:
Hallucinations
Auditory
Visual
Olfactory
Somatic/tactile
Gustatory
Clinical features:
Behavior
Bizarre dress, appearance
Catatonia
Poor impulse control
Anger, agitation
Stereotypies
Clinical features:
Mood and Affect
Inappropriate affect
Blunting of affect/mood
Flat affect
Isolation or dissociation of affect
Incongruent affect
Positive vs. negative
symptoms
Positive symptoms
Delusions
Hallucinations
Behavioral dyscontrol
Thought disorder
Negative symptoms
(Remember
Andreasen’s “A”s)
Affective flattening
Alogia
Avolition
Anhedonia
Attentional impairment
Psychotic Disorders
Onset
Schizophrenia
Usually
insidious
Delusional
disorder
Brief
psychotic
disorder
Symptoms
Many
Course
Duration
Chronic
>6 months
Varies
Delusions
(usually
only
insidious)
Chronic
>1 mo.
Sudden
Limited
<1 mo.
Varies
Psychosocial Factors
Expressed emotion
Stressful life events
Low socioeconomic class
Limited social network
Some factors rejected as
causal
“Schizophrenogenic Mother”
“Skewed” family structure
Genetic factors:
(The evidence mounts…)
Monozygotic twins (31%-78%) vs
dizygotic twins
4-9% risk in first degree relatives of
schizophrenics
Adoption studies
Linkage, molecular studies
Genetics of Schizophrenia:
The take-home message
Vulnerability to schizophrenia is
likely inherited
“Heritability” is probably 60-90%
Schizophrenia probably involves
dysfunction of many genes
Anatomical abnormalities
Enlargement of lateral ventricles
Smaller than normal total brain
volume
Cortical atrophy
Widening of third ventricle
Smaller hippocampus
Physiologic studies:
PET and SPECT
Generally normal global cerebral
flow
Hypofrontality
Failure to activate dorsolateral
prefrontal cortex (problem-solving,
adaptation, coping with changes)
Biochemical factors:
The dopamine hypothesis
All typical antipsychotics block D2
with varying affinities
Dopamine agonists can precipitate a
psychosis
Amphetamines
Cocaine
L-dopa
Dopamine systems
Cell bodies
Projections Functions
Clinical
implications
Nigrostriatal
Mesolimbic
Substantia
Nigra
Caudate
and
putamen
Movement
Extrapyramidal
symptoms, dystonias,
Tardive dyskinesia
Ventral
tegmental
area, subst.
nigra
Accumbens
amygdala
Olfactory
tubercle
Emotions,
affect,
memory
Positive symptoms
Mesocortical
Ventral
tegmental
area
Prefrontal
Cortex
Thought,
volition,
memory
Blockade here can
worsen negative
symptoms.
Typical Neuroleptics
Low potency:
Chlorpromazine
Thioridazine
Mesoridazine
High potency:
Haloperidol
Fluphenazine
Thiothixene
Loxapine (mid)
Neuroleptic (typicals):
side effects
Acute dystonia
Parkinsonian side effects (EPS)
Akathisia
Tardive dyskinesia
Sedation, orthostasis, QTC
prolongation, anticholinergic, lower
seizure threshold, increased
prolactin
Atypical Antipsychotics:
Risperidone
Olanzapine
Quetiapine
Clozapine
Ziprasidone
Aripiprazole (new-partial DA
agonist)
Atypical antipsychotics:
Broader spectrum of receptor
activity (Serotonin, dopamine,
GABA)
May be better at alleviating negative
symptoms and cognitive dysfunction
Clozaril (clozapine) associated with
agranulocytosis, seizures
Atypical Antipsychotics:
Side Effects
Sedation
Hyperglycemia, new-onset diabetes
Anticholinergic effects
Less prolactin elevation
QTC prolongation
Some EPS
Increased lipids
Psychosocial Treatment
Education, compliance #1
Hospitalize for acute loss of
functioning
Outpatient treatment is
rehabilitative
Psychoanalysis, exploratory
therapies have limited value
Families should be involved